Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Bill Would Allow 510(k) Condition-Of-Clearance Studies

This article was originally published in The Gray Sheet

Executive Summary

Legislation introduced Dec. 15 would give FDA PMA-like authorities over 510(k) devices, including the power to require post-clearance studies. Industry says the bill is unnecessary.

You may also be interested in...



CDRH Drops Seven Divisive 510(k) Proposals; Congress Picks Some Up

The device center is dropping seven controversial 510(k) reform-related proposals, including creating a “class IIb” category of devices, following pushback from industry. But some of the matters are under consideration on Capitol Hill.

FDA’s Office Of Regulatory Affairs Scrutinizes Recalls Process

Improving the efficiency of the recall process is one of ORA’s priorities for fiscal 2012. And CDRH says its own recall improvements efforts are starting to bear fruit.

Institute Of Medicine Clarifies It Is Not Seeking Tougher Bar For Class II Devices

A week after issuing a scathing assessment of FDA's 510(k) pre-market clearance program, the Institute of Medicine clarified that it is not recommending a tougher pre-market bar for all class II devices.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel